Join us for an engaging panel discussion on the "Role of Triple Drug Combination (Sitagliptin + Dapagliflozin + Metformin) in T2DM Management." Our distinguished panel of medical experts will explore the multi-faceted approach to managing Type 2 Diabetes Mellitus (T2DM), highlighting the benefits and mechanisms of this triple-drug combination. The session will include compelling case studies, an in-depth discussion on the efficacy and safety of the combination therapy, and a Q&A segment where key questions from the audience will be addressed. Don't miss this opportunity to gain valuable insights and connect with fellow healthcare professionals. Register now to secure your spot!

HID Panel Discussion

Consultant, Diabetologist, S L Raheja Hospital

Dr. Pradeep Talwalkar

2

700

16.4k

4.7

Sessions Taken

493

4.6